Use este identificador para citar ou linkar para este item:
http://www.repositorio.ufop.br/jspui/handle/123456789/15951
Título: | Detection of drug resistant mycobacterium tuberculosis strains using Kit SIRE Nitratase® : a multicenter study. |
Autor(es): | Miranda, Silvana Spindola de Almeida, Isabela Neves de Mansur, Maria de Fátima Filardi Oliveira Figueredo, Lida Jouca de Assis Carvalho, Wânia da Silva Hadaad, João Paulo Amaral Diniz, Jaciara de Lourdes do Carmo Guimarães Groll, Andrea von Silva, Pedro Almeida da Lopes, Maria Luiza Santos, Marcelo Cordeiro dos Brito, Alexandra Mello, Fernanda Carvalho de Queiroz Malaquias, Thiago da Silva Santos Croda, Julio Pinhata, Juliana Maira Watanabe Oliveira, Rosângela Siqueira de Chimara, Erica Rossetti, Maria Lúcia Halon, Maria Laura Lourenço, Maria Cristina Medeiros, Reginalda Ferreira de Melo Montes, Fátima Cristina Onofre Fandinho Machado, Diana Viveiros, Miguel Kritski, Afrânio Lineu |
Palavras-chave: | Multidrug resistant tuberculosis Nitrate reductase Technology |
Data do documento: | 2020 |
Referência: | MIRANDA, S. S. de et al. Detection of drug resistant mycobacterium tuberculosis strains using Kit SIRE Nitratase®: a multicenter study. Brazilian Archives of Biology and Technology, v. 63, 2020. Disponível em: <https://www.scielo.br/j/babt/a/rwZ8F449jqmSRmgWcqgFdxc/?lang=en>. Acesso em: 11 out. 2022. |
Resumo: | (1) Background: The Commercial Kit SIRE Nitratase® PlastLabor, is a drug susceptibility test kit used to detect Mycobacterium tuberculosis resistance to first-line TB treatment drugs. The present study aimed at evaluating its performance in a multicenter study. (2) Methods: To determine its accuracy, the proportion methods in Lowenstein Jensen medium or the BACTECTMMGITTM960 system was used as a gold standard. (3) Results: The study revealed that the respective accuracies of the kit with 190 M. tuberculosis clinical isolates, using the proportion methods in Lowenstein Jensen medium or BACTECTMMGITTM960 system as a gold standard, were 93.9% and 94.6%, 96.9% and 94.6%, 98.0% and 97.8%, and 98.0% and 98.9%, for streptomycin, isoniazid, rifampicin, and ethambutol, respectively. (4) Conclusion: Thus, the kit can rapidly screen resistance to streptomycin, isoniazid, rifampicin, and ethambutol. Additionally, it does not require sophisticated equipment; hence, it can be easily used in the laboratories of low and middle income countries. |
URI: | http://www.repositorio.ufop.br/jspui/handle/123456789/15951 |
DOI: | https://doi.org/10.1590/1678-4324-2020190179 |
ISSN: | 1678-4324 |
Licença: | Submitted for possible open access publication under the terms and conditions of the Creative Commons Attribution (CC BY NC) license (https://creativecommons.org/licenses/by-nc/4.0/). Fonte: o PDF do artigo. |
Aparece nas coleções: | DEACL - Artigos publicados em periódicos |
Arquivos associados a este item:
Arquivo | Descrição | Tamanho | Formato | |
---|---|---|---|---|
ARTIGO_DetectionDrugResistant.pdf | 242,23 kB | Adobe PDF | Visualizar/Abrir |
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.